These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 18661488

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

  • 3. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov 10; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 10; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 6. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K.
    Prenat Diagn; 2004 Oct 10; 24(10):762-6. PubMed ID: 15503281
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contingent screening for Down syndrome--results from the FaSTER trial.
    Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JC, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, D'Alton ME.
    Prenat Diagn; 2008 Feb 10; 28(2):89-94. PubMed ID: 18236423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-stage contingent screening for Down syndrome.
    Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P.
    Prenat Diagn; 2006 Jun 10; 26(6):528-34. PubMed ID: 16634118
    [Abstract] [Full Text] [Related]

  • 14. Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women.
    Guanciali-Franchi P, Iezzi I, Palka C, Matarrelli B, Morizio E, Calabrese G, Benn P.
    Prenat Diagn; 2011 Nov 10; 31(11):1077-81. PubMed ID: 21800336
    [Abstract] [Full Text] [Related]

  • 15. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ, Rudnicka AR, Bestwick JP.
    Prenat Diagn; 2006 Sep 10; 26(9):769-77. PubMed ID: 16821246
    [Abstract] [Full Text] [Related]

  • 16. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ, Bestwick JP, Morris JK.
    Prenat Diagn; 2006 Jun 10; 26(6):514-23. PubMed ID: 16739232
    [Abstract] [Full Text] [Related]

  • 17. Repeated measures screening for Down's Syndrome.
    Wright DE, Bradbury I.
    BJOG; 2005 Jan 10; 112(1):80-3. PubMed ID: 15663402
    [Abstract] [Full Text] [Related]

  • 18. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP, Huttly WJ, Wald NJ.
    J Med Screen; 2008 Jan 10; 15(4):204-6. PubMed ID: 19106261
    [Abstract] [Full Text] [Related]

  • 19. Practical strategies in contingent sequential screening for Down syndrome.
    Benn P, Wright D, Cuckle H.
    Prenat Diagn; 2005 Aug 10; 25(8):645-52. PubMed ID: 16049988
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
    Spencer K, Aitken D.
    Ultrasound Obstet Gynecol; 2004 Dec 10; 24(7):735-9. PubMed ID: 15505874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.